STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On November 17, 2022, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register adding Amineptine into schedule I of the federal Controlled Substances Act. The scheduling action is effective December 19, 2022.
2. The Controlled Substances Board did not receive an objection to similarly listing Amineptine as a schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing Amineptine as a schedule I controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rulemaking, listing Amineptine as a schedule I controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Amineptine under chapter 961, Stats. by creating the following: CSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read:
961.14 (7) (r) 7-[10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino ]heptanoic acid, commonly known as Amineptine.
This order shall become effective upon publication in the Administrative Register. The order expires upon promulgation of a final rule.
